Valvular Heart Disease (VHD)
Conditions
Interventions
Study group:Warfarin Knowledge Assessment
Control group:Traditional missionary work
Sponsors
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients undergoing cardiac valve surgery who require warfarin therapy (at least 3 months) were eligible for this study. Participants must be capable of completing follow-up via mobile phone or with assistance from family members, provide signed informed consent, and be aged between 18 and 80 years.
Exclusion criteria
Exclusion criteria: Patients with mental illness or cognitive impairments unable to comply with the intervention, individuals planning to undergo unscheduled surgical procedures during the study period, participants with a history of severe gastrointestinal conditions, subjects with contraindications to warfarin therapy, and women planning or currently pregnant were excluded from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time in therapeutic range (TTR) at 3 months postoperatively; | — |
Secondary
| Measure | Time frame |
|---|---|
| Medication Adherence;Incidence rate; | — |
Countries
China
Contacts
Public ContactHuafeng Zhang
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Outcome results
None listed